Clinical trial Recruiting at 1 site Observational Ages 65 and up

Remimazolam versus Midazolam for anesthesia induction in older adults

Official title: Effectiveness and Safety of Remimazolam Compared With Midazolam for General Anesthesia Induction in Elderly Patients Undergoing Non-Cardiac Surgery: A Prospective Observational Cohort Study

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07746505 · Data updated 2026-11-12

This observational study compares remimazolam and midazolam when inducing anesthesia in people aged 65 and older undergoing elective non-cardiac surgery to see which provides better stability and safety.

More Anxiety trials

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment1000 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations1 site (Hangzhou)
StatusRecruiting
StartedJune 15, 2026
Main results expectedJune 16, 2027
Study endsJuly 15, 2027
Registry record updatedAugust 5, 2026
Trial IDNCT07746505 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 65 and older scheduled for elective non-cardiac surgery with planned general anesthesia and airway management, who can provide informed consent.

Probably not a fit

Patients with benzodiazepine contraindications, preexisting cognitive impairment (MMSE <18), recent benzodiazepine use, or inability to consent may not benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cohort study records real-world use of two benzodiazepine sedatives—remimazolam and midazolam—during induction of general anesthesia in elderly patients. Patients are grouped by the sedative actually used, with anesthesiologists selecting the agent per routine practice. Data collected include demographics, medical history, intraoperative variables, hemodynamic events, drug doses, fluid balance, blood loss, and recovery outcomes. Propensity score methods will be applied to adjust for confounding and compare outcomes. The study does not modify standard care and aims to characterize safety and hemodynamic performance in this vulnerable population.

Why it matters

Potential benefit: If remimazolam shows better hemodynamic stability and faster recovery, it could improve safety and efficiency of anesthesia induction in elderly patients.

How similar studies have gone: Prior research suggests remimazolam may offer stable hemodynamics and rapid emergence, but evidence in elderly surgical patients remains observational and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 65 years or older.
2. Scheduled for elective non-cardiac surgery under general anesthesia.
3. American Society of Anesthesiologists physical status I to IV.
4. Planned airway management with tracheal intubation or a laryngeal mask airway.
5. Written informed consent provided by the participant or the participant's legally authorized representative.

   \-

Exclusion Criteria:

1. Long-term preoperative benzodiazepine use.
2. Known allergy or contraindication to benzodiazepines, flumazenil, opioids, naloxone, or related drugs.
3. History of drug abuse or alcoholism within the past 2 years.
4. No preoperative cognitive assessment available.
5. Preoperative cognitive impairment, defined as a Mini-Mental State 6.Examination score less than 18.

7.Refusal to provide informed consent.

\-

Where it's running

  • The Second Affiliated Hospital of Zhejiang University School of Medicin
    Hangzhou, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.